Dose and duration shape the efficacy of vonoprazan versus lansoprazole for erosive esophagitis: insights from meta-regression. [PDF]
Huang PF, Chen HW, Liang YJ.
europepmc +1 more source
Proton Pump Inhibitors and Risk of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]
Almabruk BA +8 more
europepmc +1 more source
Evaluation of the Safety and Efficacy of K-CAB (Tegoprazan) as Symptomatic Maintenance Therapy in Patients With NERD: A Multicenter, Randomized Double-Blinded Controlled Trial. [PDF]
Kwon YH +11 more
europepmc +1 more source
Allergic diseases of the skin and drug allergies – 2027. Successful treatment with intravenous immunoglobulin and prednisolone pulse therapy of toxic epidemal necrolysis and Stevens-Johnson Syndrome [PDF]
Arzu Yalcin +4 more
core +1 more source
Patients' perception of proton pump inhibitors use and their risks. [PDF]
Sawaied IO, Samson AO, Golan E.
europepmc +1 more source
Integrative pharmacovigilance and AI-based framework uncovers potential drug triggers in juvenile idiopathic arthritis. [PDF]
Luo Q +9 more
europepmc +1 more source
Analysis of infection-related adverse events induced by proton pump inhibitors based on the FAERS and JADER databases. [PDF]
Hu S, Yu H, Liu Z.
europepmc +1 more source
Tegoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial. [PDF]
Park JY +19 more
europepmc +1 more source
Efficacy of Vonoprazan in Nonsteroidal Anti-Inflammatory Drug-Induced Ulcer in Terms of Ulcer Recurrence and Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. [PDF]
Bandyopadhyay S, Samajdar SS, Das S.
europepmc +1 more source
The Effect of Tegoprazan on Serum Gastrin Levels and the Development of Hypergastrinemia in the Maintenance Treatment for Gastroesophageal Reflux Disease: Comparison to Lansoprazole. [PDF]
Lee KJ, Jung DH, Lee OY.
europepmc +1 more source

